# Bioequivalence Study of Clindamycin Phosphate Topical Lotion, 1% in Subjects With Acne Vulgaris

> **NCT03717506** · PHASE3 · COMPLETED · sponsor: **Balmoral Medical company** · enrollment: 1236 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** GDC 268 Lotion
- **DRUG:** Clindamycin Phosphate Lotion 1%
- **DRUG:** GDC Vehicle Lotion

## Key facts

- **NCT ID:** NCT03717506
- **Lead sponsor:** Balmoral Medical company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-10
- **Primary completion:** 2020-02-17
- **Final completion:** 2020-04-16
- **Target enrollment:** 1236 (ACTUAL)
- **Last updated:** 2021-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03717506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03717506, "Bioequivalence Study of Clindamycin Phosphate Topical Lotion, 1% in Subjects With Acne Vulgaris". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT03717506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*